How a key pancreatic protein shapes insulin-producing beta cell growth
Structure dictates dynamic topology and function of pancreatic transcriptional regulators
['FUNDING_R01'] · UNIVERSITY OF PENNSYLVANIA · NIH-11252362
Researchers are exploring how changes in the shape and behavior of the Pdx1 protein affect insulin-producing beta cells to help people with diabetes.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-11252362 on ClinicalTrials.gov |
What this research studies
This project looks at how the Pdx1 protein, which helps control genes in insulin-producing beta cells, moves inside the cell and changes during growth. Scientists will study a flexible tail region of Pdx1 and how it helps form 3-D gene-regulating hubs that turn on programs for beta-cell division and function. The team will use molecular and cell biology techniques, cell-cycle analyses, and 3-D genome mapping to see how altering Pdx1 levels or structure affects beta-cell survival and expansion. Findings are intended to reveal molecular rules that could inform future approaches to preserve or restore beta-cell mass.
Who could benefit from this research
Good fit: People living with diabetes who are interested in research aimed at preserving or restoring insulin-producing beta cells would be the most relevant group to follow this work or participate in future related trials.
Not a fit: Patients needing immediate glucose-lowering treatment or urgent medical care are unlikely to receive direct benefit from this basic laboratory research.
Why it matters
Potential benefit: If successful, this work could point to new ways to preserve or restore insulin-producing beta cells and ultimately improve treatments for people with diabetes.
How similar studies have performed: Prior studies have established that Pdx1 is critical for beta-cell function, but focusing on its disordered tail and 3-D enhancer hub roles is a newer approach that remains to be fully tested.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: STOFFERS, DORIS A — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: STOFFERS, DORIS A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.